CoTherix Acquires Schering's U.S. Rights For Ventavis, Raises $55M Oct. 15, 2003 By Karen Carey No Comments The company formerly known as Exhale Therapeutics Inc. has acquired a new name, a new financing and new U.S. rights to a pulmonary hypertension product. (BioWorld Today)Read More
Xcyte Seeking $75M In Second Attempt At Initial Public Offering Oct. 14, 2003 By Karen Carey No Comments
ID Biomedical Raising $100M To Advance FluINsure, StreptAvax Oct. 10, 2003 By Karen Carey No Comments
